Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Vogel

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
American Heart Journal|April 24, 2023
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registryAlessandro Spirito, Won-Joon Koh, Samantha Sartori, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
Journal of the American College of Cardiology|February 15, 2020
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet SubstudyUsman Baber, M Urooj Zafar, George Dangas, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
Journal of the American College of Cardiology|January 25, 2023
Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery DiseaseSerdar Farhan, Florian K Enzmann, Patrick Bjorkman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Heart (British Cardiac Society)|August 4, 2025
Predictors of postprocedural troponin increase in patients undergoing elective percutaneous coronary interventionSean Gilhooley, Mauro Gitto, Alessandro Spirito, et al.
Journal of the American College of Cardiology|April 8, 2022
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7Mario Gaudino, Antonino Di Franco, Davide Cao, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
American Heart Journal|April 24, 2023
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registryAlessandro Spirito, Won-Joon Koh, Samantha Sartori, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
Journal of the American College of Cardiology|February 15, 2020
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet SubstudyUsman Baber, M Urooj Zafar, George Dangas, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
Journal of the American College of Cardiology|January 25, 2023
Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery DiseaseSerdar Farhan, Florian K Enzmann, Patrick Bjorkman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Heart (British Cardiac Society)|August 4, 2025
Predictors of postprocedural troponin increase in patients undergoing elective percutaneous coronary interventionSean Gilhooley, Mauro Gitto, Alessandro Spirito, et al.
Journal of the American College of Cardiology|April 8, 2022
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7Mario Gaudino, Antonino Di Franco, Davide Cao, et al.
Pageof 19